| Title |
Author |
Type |
Date |
Words |
| immatics Wins 2012 TiE50 Award. |
|
|
May 25, 2012 |
594 |
| BiovaxID[R] Personalized Lymphoma Vaccine is Featured in Article Published in Scrip Intelligence. |
|
|
May 22, 2012 |
888 |
| Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine. |
|
|
May 17, 2012 |
1204 |
| Biovest Retains Ferghana Partners to Evaluate Strategic Transactions. |
|
|
May 16, 2012 |
723 |
| Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers. |
|
|
May 15, 2012 |
1244 |
| CEL-SCI's Chief Scientific Officer Presents at Cancer Symposium. |
|
|
May 15, 2012 |
594 |
| Biovest to Seek Marketing Approval in the EU for BiovaxID[R] Personalized Lymphoma Cancer Vaccine. |
|
|
May 14, 2012 |
1511 |
| 1.5million cancer deaths caused by curable infections; LOW-COST VACCINES COULD HELP PREVENT MANY CASES. |
|
|
May 9, 2012 |
529 |
| ImmunoCellular Provides an Update on Enrollment for the Company's Phase II Clinical Trial. |
|
|
May 9, 2012 |
687 |
| Profectus BioSciences, Inc. Receives $5.6M Grant to Develop a Vaccine to Protect Humans against Infection with Nipah/Hendra Viruses. |
|
|
May 9, 2012 |
1094 |
| Biovest to Present at Cancer Immunotherapy Leaders Forum. |
|
|
May 7, 2012 |
578 |
| Biovest Announces that New Clinical Data for BiovaxID[R] Personalized Cancer Vaccine will be Presented by National Cancer Institute at ASCO. |
|
|
May 3, 2012 |
793 |
| Preventive services for older adults: recommendations and Medicare coverage. |
Goldberg, Todd H. |
Report |
May 1, 2012 |
3752 |
| PsiOxus Therapeutics Moves into New Facilities on Milton Park to Accommodate Expansion. |
|
|
Apr 24, 2012 |
596 |
| Biovest Interviewed by OneMedRadio Regarding Global Regulatory Strategy to Seek Approvals for BiovaxID[R] Cancer Vaccine. |
|
|
Apr 19, 2012 |
1154 |
| Tumour vaccine offers new hope; WORLD TODAY HEALTH. |
|
|
Apr 18, 2012 |
126 |
| Advaxis Awarded Best Therapeutic Vaccine. |
|
Awards list |
Apr 12, 2012 |
826 |
| Biovest to Seek Marketing Approval for BiovaxID[R] Personalized Lymphoma Cancer Vaccine in Canada. |
|
|
Apr 10, 2012 |
1431 |
| Attend BIO tech 2012 Conference to Grab the Latest Trends on "Vaccines", Whose Market is Greatly Expanding. - Asia's Largest Bio Event. |
|
Conference news |
Apr 10, 2012 |
796 |
| Advaxis Announces Presentations at World Vaccine Congress 2012. |
|
|
Apr 10, 2012 |
617 |
| Soon, wonder jab that will kill 90pc of cancers. |
|
|
Apr 9, 2012 |
397 |
| Biovest Announces International Members of its Cancer Vaccine Scientific Advisory Board. |
|
|
Apr 3, 2012 |
1059 |
| Agenus Presents at Cowen Health Care Conference. |
|
Conference news |
Mar 31, 2012 |
430 |
| Biovest Establishes World Class Scientific Advisory Board Comprised of Key Opinion Leaders in the Fields of Cancer Immunotherapy, Bioinformatics and Cell Culture Systems. |
|
|
Mar 27, 2012 |
1164 |
| Researcher for compulsory vaccination against HPV. |
|
|
Mar 25, 2012 |
335 |
| Advaxis Continues Collaboration with Former NCI Vaccines Chief in New Position as Director of the Georgia Health Sciences University Cancer Center. |
|
|
Mar 20, 2012 |
921 |
| BiovaxID[R] Personalized Lymphoma Vaccine is Featured in Article Published in Drug Discovery News. |
|
|
Mar 15, 2012 |
988 |
| Research and Markets: Cancer Vaccine Partnering Agreements - Discover the Trends in Cancer Vaccine Dealmaking. |
|
|
Mar 7, 2012 |
430 |
| ImmunoCellular Therapeutics Licenses Mesothelin Cancer Antigen from Johns Hopkins University. |
|
|
Feb 29, 2012 |
547 |
| Research and Markets: Analytical Tool - Cancer Vaccines - 2012 Provides You With An Immense Amount Of Information Structured And Analyzed To Assist You In Your Work. |
|
|
Feb 28, 2012 |
336 |
| ImmunoCellular Therapeutics Announces Licensing Agreement with University of Pennsylvania for Enhanced Dendritic-Cell Production Technology. |
|
|
Feb 21, 2012 |
764 |
| New Defense Mechanism against Viruses, Cancer Identified. |
|
Disease/Disorder overview |
Feb 16, 2012 |
453 |
| Biovest to Present on BiovaxID[R] Personalized Lymphoma Vaccine at San Francisco Cancer Biologics Conference. |
|
Conference news |
Feb 16, 2012 |
790 |
| Research and Markets: Triple Analysis: Angiogenesis, Cancer Vaccines and Peptides. |
|
|
Feb 14, 2012 |
487 |
| OncoPep Enters Exclusive License Agreement with Dana-Farber for Novel Therapeutic Multi-Peptide Vaccine Technology for Hematologic Cancers. |
|
|
Feb 13, 2012 |
341 |
| BioLife Solutions Congratulates DCPrime on Its Approved Orphan Medicinal Product Application for DCOne*a Leukemia Vaccine. |
|
|
Feb 6, 2012 |
1130 |
| No one should die from cervical cancer, says Lebanese expert. |
|
|
Feb 2, 2012 |
945 |
| European Medicines Agency Approves Orphan Medicinal Product Application of DCPrime's Acute Myeloid Leukemia Vaccine. |
|
|
Feb 1, 2012 |
443 |
| New vaccine approach for treatment of cancer discovered. |
|
|
Jan 28, 2012 |
332 |
| First Preclinical Proof-of-Concept of Mutation-Based Individualized Cancer Vaccine. |
|
|
Jan 17, 2012 |
689 |
| Campaign launched to raise awareness on cervical cancer. |
|
|
Jan 12, 2012 |
423 |
| Cut in cervical cancer screening fee by 50%. |
|
|
Jan 11, 2012 |
487 |
| Article Published on Fox News Website Predicts the Advance of Cancer Vaccines in 2012 including BiovaxID[R] Lymphoma Vaccine. |
|
|
Jan 10, 2012 |
1036 |
| Midatech Secures 6.3 Million Financing to Strengthen Product Development Portfolio. |
|
|
Jan 5, 2012 |
636 |
| Cervical cancer screening - a new viral paradigm: cervical cancer is the second most frequent cancer among women in South Africa and worldwide. |
Richter, Karin Louise |
|
Jan 1, 2012 |
2705 |
| Whale sperm and orgasmic feet top 2011 bad science list. |
|
|
Dec 28, 2011 |
583 |
| Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television. |
|
|
Dec 21, 2011 |
723 |
| BiovaxID[R] Lymphoma Vaccine is Featured in Article Published in Yale Journal of Biology and Medicine. |
|
|
Dec 20, 2011 |
705 |
| Generex Provides Update on Bloomberg TV Breast Cancer Vaccine Segment. |
|
|
Dec 20, 2011 |
694 |
| Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today. |
|
Clinical report |
Dec 19, 2011 |
1018 |
| HPV vaccine does not encourage sexually risky activity in girls. |
|
|
Dec 18, 2011 |
447 |
| BiovaxID[R] Lymphoma Vaccine is Featured in Articles Published in Newsweek and Genetic Engineering & Biotechnology News. |
|
|
Dec 15, 2011 |
688 |
| Soon, vaccine that can shrink tumours by 80pc! |
|
|
Dec 13, 2011 |
522 |
| Super vaccine that could tackle 70pc of lethal cancers coming by 2020! |
|
|
Dec 13, 2011 |
346 |
| Profectus BioSciences, Inc. Receives $5.4M Grant to Develop a Monocolonal Antibody Against Infection by Nipah/Hendra Viruses. |
|
|
Dec 13, 2011 |
769 |
| SCANCELL HOLDINGS PLC - Issue of Equity. |
|
|
Dec 13, 2011 |
529 |
| Scientists Develop Vaccine That Successfully Attacks Breast Cancer in Mice. |
|
|
Dec 13, 2011 |
858 |
| Novel Cancer Treatment Combination Receives Approval to Begin First-in-Human Testing for Patients with Advanced Metastatic Melanoma. |
|
|
Dec 8, 2011 |
1149 |
| MDxHealth Enters Agreement with Celldex for Use of MGMT Epigenetic Test in Phase III Rindopepimut Study in Brain Cancer. |
|
Clinical report |
Dec 2, 2011 |
651 |
| Celldex Initiates ACT IV, a Pivotal International Phase 3 Trial of Rindopepimut in Patients with Glioblastoma. |
|
|
Dec 1, 2011 |
1588 |
| European $620 Cancer Vaccine Finds USA Funding with Mentor Capital. |
|
|
Nov 28, 2011 |
389 |
| Research and Markets: Triple Analysis: Leukemia, Cancer Vaccines and Antibodies. |
|
|
Nov 28, 2011 |
342 |
| THE vaccine used to protect [...]. |
|
|
Nov 28, 2011 |
250 |
| Women urged to screen for cervical cancer regularly. |
|
|
Nov 26, 2011 |
463 |
| Cervical cancer vaccine change. |
|
|
Nov 26, 2011 |
171 |
| Research and Markets: Triple Analysis: Leukemia, Cancer Vaccines and Peptides. |
|
|
Nov 25, 2011 |
488 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Cancer Vaccines and Antibodies. |
|
|
Nov 23, 2011 |
449 |
| Biovest Defines Role of BiovaxID[R] Personalized Cancer Vaccine in Journal of Clinical Oncology. |
|
|
Nov 22, 2011 |
787 |
| Selecta Biosciences Initiates Phase 1 Clinical Study of SEL-068, a First-in-Class Synthetic Nicotine Vaccine for Smoking Cessation and Relapse Prevention. |
|
|
Nov 21, 2011 |
825 |
| Top 10 Myths About HIV Vaccine Research (Dec. 1 is World Aids Day). |
|
|
Nov 18, 2011 |
1487 |
| ImmunoCellular Therapeutics to Present at the 16th Annual Meeting of the Society for Neuro-Oncology. |
|
|
Nov 18, 2011 |
627 |
| SCANCELL HOLDINGS PLC - Holdings in Company. |
|
|
Nov 17, 2011 |
438 |
| Profectus BioSciences Awarded Follow-on Grant from PATH Malaria Vaccine Initiative (MVI). |
|
|
Nov 15, 2011 |
624 |
| Northwest Bio to Present at Society of Neuro-Oncology Annual Meeting. |
|
|
Nov 15, 2011 |
1026 |
| Research and Markets: Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market. |
|
|
Nov 8, 2011 |
587 |
| Research and Markets: Competitor Analysis: Cancer Vaccines. |
|
|
Nov 7, 2011 |
337 |
| SCANCELL HOLDINGS PLC - Confirmation of GBP2.85 million payment. |
|
|
Nov 4, 2011 |
832 |
| Vaccination: a public health intervention that changed history & is changing with history. |
Stein, Richard A. |
|
Nov 1, 2011 |
6126 |
| HPV vaccine myths put health, lives at risk, say health leaders. |
Tucker, Charlotte |
|
Nov 1, 2011 |
1145 |
| HPV goes beyond cervical cancer. |
|
Brief article |
Nov 1, 2011 |
256 |
| Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling. |
|
Clinical report |
Oct 31, 2011 |
1928 |
| Mentor Capital Adds to European Cancer Portfolio with AGI Biopharmaceuticals Melanoma Vaccine. |
|
|
Oct 31, 2011 |
286 |
| Vaccine boosts fight against cervical cancer. |
|
|
Oct 31, 2011 |
384 |
| Research and Markets: Cancer Vaccines: Second Edition. |
|
|
Oct 28, 2011 |
388 |
| HPV for Boys Doesn't Solve Problem, Says Association of American Physicians and Surgeons. |
|
|
Oct 27, 2011 |
656 |
| RUSNANO invests in Selecta Biosciences and BIND Biosciences to develop and commercialize vaccines and cancer drugs through expanded operations in Russia. |
|
|
Oct 27, 2011 |
1524 |
| Biovest Announces that FDA Grants Orphan Drug Status for Personalized Cancer Vaccine for the Treatment of Waldenstrom's Macroglobulinemia, a Rare Subtype of Non-Hodgkin's Lymphoma. |
|
|
Oct 27, 2011 |
870 |
| Research and Markets: Cancer Vaccines: From Development to Clinical Practice. |
|
|
Oct 25, 2011 |
381 |
| CDC Advisory Committee on Immunization Practices Votes for Expanded Use of GARDASIL[R] in Boys and Young Men. |
|
|
Oct 25, 2011 |
1918 |
| SCANCELL HOLDINGS PLC - Progress on possible GBP2.85m payment. |
|
|
Oct 25, 2011 |
643 |
| AN infectious bug has for [...]. |
|
|
Oct 24, 2011 |
247 |
| SCANCELL HOLDINGS PLC - SCIB 1 Patent Awarded. |
|
|
Oct 20, 2011 |
537 |
| Companies & Markets: Cancer Vaccines Market Set to Change. |
|
|
Oct 20, 2011 |
375 |
| CANCER'S CATCHING; Experts: Nearly half of cases linked to viruses. |
|
|
Oct 17, 2011 |
228 |
| VIRUSES LINKED TO 40 PER CENT OF ALL CANCERS; Research may lead to new vaccines. |
|
|
Oct 17, 2011 |
282 |
| Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018. |
|
|
Oct 17, 2011 |
3531 |
| Research and Markets: Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies. |
|
|
Oct 17, 2011 |
415 |
| Perry "Hates" Cancer, but Budget Cuts Slash Cervical Cancer Screenings. |
|
|
Oct 17, 2011 |
1126 |
| Research and Markets: Cancer Drug Development Strategies in Lymphoma, Vaccines and Peptides. |
|
|
Oct 12, 2011 |
413 |
| Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial. |
|
|
Oct 11, 2011 |
563 |
| Research and Markets: Vaccines in Clinical Trials: Cancer - 12 Fascinating Review-Length Articles. |
|
|
Oct 11, 2011 |
397 |
| Research and Markets: Lung Cancer Vaccines: 2011 Pipeline, Strategies and Clinical. |
|
Clinical report |
Oct 11, 2011 |
530 |
| ImmunoCellular Therapeutics Receives Notice of Allowance of Key U.S. Patent for Lead Product Candidate. |
|
|
Oct 10, 2011 |
561 |
| Research and Markets: Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical. |
|
|
Oct 7, 2011 |
503 |
| Inovio Pharmaceuticals' Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress. |
|
|
Oct 5, 2011 |
1167 |
| ImmunoCellular Therapeutics to Present at the Annual Meeting of the Congress of Neurological Surgeons. |
|
|
Oct 5, 2011 |
504 |
| BioSante Pharmaceuticals, Inc. To Present at Cancer Immunotherapy Conference. |
|
Conference news |
Oct 3, 2011 |
449 |
| Biovest to Present on Regulatory Strategy for BiovaxID[R] Cancer Vaccine at MD Becker Cancer Immunotherapy Conference. |
|
Conference news |
Oct 3, 2011 |
683 |
| Lung cancer vaccine. |
|
|
Oct 1, 2011 |
196 |
| Inovio Pharmaceuticals to Present at Scientific Conferences. |
|
Conference news |
Sep 30, 2011 |
1122 |
| Biovest's Personalized Cancer Vaccine Targeting Non-Hodgkin's Lymphoma Featured in 'HemOnc Today' Cover Story. |
|
|
Sep 29, 2011 |
881 |
| ImmunoCellular Therapeutics' ICT-107 Recognized As One Of Windhover's Top 10 Most Licensable Oncology Products. |
|
|
Sep 28, 2011 |
750 |
| Aptiv Solutions Awarded Pivotal International Cancer Vaccine Trial. |
|
|
Sep 28, 2011 |
682 |
| Money splice infuses RXi; Cancer vaccine business spinoff. |
|
|
Sep 27, 2011 |
610 |
| Wistar Institute Breaks Ground on $100 Million Expansion. |
|
|
Sep 23, 2011 |
901 |
| Wistar Institute Announces $35 Million Capital Campaign. |
|
|
Sep 23, 2011 |
933 |
| Swedish's Ivy Brain Tumor Center Launches Two New Clinical Trials to Treat Brain Cancer. |
|
|
Sep 21, 2011 |
2175 |
| Antigen Express' AE37 Cancer Vaccine Featured in Scientific American. |
|
|
Sep 21, 2011 |
1234 |
| Profectus BioSciences In-Licenses Portfolio of Patents to Support Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses. |
|
|
Sep 21, 2011 |
401 |
| Minnesota Researchers Look to Body's Immune System to Prevent Breast Cancer, with Funding from Susan G. Komen for the Cure[R]. |
|
|
Sep 20, 2011 |
641 |
| Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy. |
|
|
Sep 19, 2011 |
1414 |
| Biovest to Exhibit at Lymphoma Research Foundation Annual Forum. |
|
|
Sep 15, 2011 |
858 |
| The Brief: Sept. 14, 2011. |
|
|
Sep 14, 2011 |
803 |
| DePinho: Opposing HPV Vaccine "Unethical". |
|
|
Sep 13, 2011 |
370 |
| MONEY BRIEFS. |
|
|
Sep 13, 2011 |
476 |
| Cancer Cure Lottery: 10 Vaccine Treatments To Be Given Away Over 5-Week Period. |
|
|
Sep 13, 2011 |
381 |
| Merck Partners with Susan G. Komen for the Cure[R] on Historic Initiative to Help Address Cervical and Breast Cancer in Developing Nations. |
|
|
Sep 13, 2011 |
1341 |
| ImmunoCellular Therapeutics Announces 55% Overall Survival at Three years from Phase I Study in Glioblastoma. |
|
|
Sep 12, 2011 |
804 |
| Juvaris BioTherapeutics Announces License to Colby Pharmaceutical Company for JVRS-100 and CLDC (Cationic Lipid-DNA Complex) Platform for Human Health. |
|
|
Sep 9, 2011 |
659 |
| Inovio Pharmaceuticals to Present at Scientific Conferences. |
|
Conference news |
Sep 7, 2011 |
1111 |
| ImmunoCellular Therapeutics gives Site Update for Phase II trial of ICT-107. |
|
|
Sep 7, 2011 |
809 |
| Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board. |
|
|
Sep 6, 2011 |
1437 |
| Cancer nearly stole my fertility. |
|
|
Sep 5, 2011 |
600 |
| Immune cells can be helpful as well as harmful in fighting infection, finds study. |
|
|
Aug 27, 2011 |
290 |
| Mayo Clinic Receives FDA Approval for Ovarian and Breast Cancer Vaccines. |
|
|
Aug 22, 2011 |
465 |
| SCANCELL HOLDINGS PLC - Holding(s) in Company. |
|
|
Aug 19, 2011 |
434 |
| MMR at record levels; Protective jabs level hits a high. |
|
|
Aug 18, 2011 |
351 |
| SCANCELL HOLDINGS PLC - SCIB1: Safety Review and Dose Escalation. |
|
|
Aug 17, 2011 |
613 |
| Scientists a step closer to Hepatitis C vaccine. |
|
|
Aug 5, 2011 |
536 |
| New approach lifts hope for hepatitis C vaccine. |
|
|
Aug 4, 2011 |
315 |
| Research and Markets: The Vaccines Market in the US is set to Reach over $15 billion by 2015. |
|
|
Aug 3, 2011 |
476 |
| Medicare to cover prostate cancer vaccine. |
Ault, Alicia |
|
Aug 1, 2011 |
548 |
| World's first skin cancer vaccine may be available within 1 year. |
|
|
Jul 31, 2011 |
195 |
| VaxOnco to Sponsor Phase I Trial of a Folate Receptor Alpha-targeted Breast/Ovarian Cancer Therapeutic Vaccine That Recently Received Investigational New Drug Approval From FDA. |
|
|
Jul 25, 2011 |
400 |
| BioSante Pharmaceuticals Signs Melanoma Vaccine License. |
|
|
Jul 21, 2011 |
983 |
| Aeterna Zentaris Successfully Reached a Key Milestone in the Non-Clinical Development of its Oral Prostate Cancer Vaccine Candidate, AEZS-120. |
|
|
Jul 20, 2011 |
941 |
| MONEY BRIEFS. |
|
|
Jul 14, 2011 |
597 |
| Adamis Vaccine Technology Granted a Patent in Europe. |
|
|
Jul 13, 2011 |
708 |
| OncoSec Medical to Present at DNA Vaccines Conference 2011. |
|
Conference news |
Jul 11, 2011 |
589 |
| Inovio Expands DNA Vaccine Intellectual Property License With the University of Pennsylvania. |
|
|
Jul 7, 2011 |
1005 |
| Biovest's Personalized Lymphoma Vaccine Featured in Cancer Research Institute/MD Becker Partners Cancer Immunotherapy Report. |
|
|
Jul 7, 2011 |
758 |
| New Comprehensive Drugs and Biotechnology Reviews Recently Published by MarketPublishers.com. |
|
Clinical report |
Jul 5, 2011 |
482 |
| Inovio Pharmaceuticals' DNA Vaccine for Foot-and-Mouth Disease Generates Protective Neutralizing Antibodies in Second Large-Animal Study. |
|
|
Jun 30, 2011 |
1696 |
| SCANCELL HOLDINGS PLC - Placing to raise [pounds]1.73 million. |
|
|
Jun 30, 2011 |
4309 |
| SCANCELL HOLDINGS PLC - Change of Board Structure. |
|
|
Jun 30, 2011 |
512 |
| A NEW kind of "shotgun" [...]. |
|
|
Jun 27, 2011 |
245 |
| ImmunoCellular Therapeutics to Present at 2nd World Cancer Vaccines Summit. |
|
|
Jun 22, 2011 |
748 |
| Prejudicial distribution of the HPV vaccine. |
Gullion, Jessica Smartt |
Essay |
Jun 22, 2011 |
5306 |
| ImmunoCellular Therapeutics' Cancer Vaccine Technology Issued Key Patent. |
|
|
Jun 21, 2011 |
803 |
| Mayo Clinic Researchers Use Human Vaccine to Cure Prostate Cancer in Mice. |
|
|
Jun 21, 2011 |
769 |
| VIRUS KEY TO CANCER. |
|
|
Jun 20, 2011 |
224 |
| 'Shotgun' vaccine tackles prostate cancer. |
|
|
Jun 20, 2011 |
113 |
| Cancer jab that will 'seek and destroy' tumours developed. |
|
|
Jun 20, 2011 |
284 |
| Researchers create vaccine from 'library of DNA' to treat cancer. |
|
|
Jun 20, 2011 |
357 |
| Human vaccine successfully destroys advanced prostate cancer in mice. |
|
|
Jun 20, 2011 |
193 |
| HPV vaccine 'could slash cancer 50%' health. |
|
|
Jun 17, 2011 |
108 |
| VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival. |
|
|
Jun 17, 2011 |
1257 |
| Vaccine against cervical cancer works successfully. |
|
|
Jun 17, 2011 |
264 |
| Cancer vaccine working. |
|
|
Jun 17, 2011 |
108 |
| First Patients are Vaccinated in IMPRINT*, immatics' Pivotal Phase III Trial With IMA901 in Patients With Renal Cell Carcinoma (RCC). |
|
|
Jun 15, 2011 |
890 |
| Researchers envisage 20 new vaccines to fight likes of malaria in next decade. |
|
|
Jun 10, 2011 |
277 |
| Inovio Pharmaceuticals Subsidiary, VGX Animal Health, to Present at VetHealth Global 2011, June 14-17, 2011. |
|
|
Jun 9, 2011 |
991 |
| ImmunoCellular Therapeutics Ltd. Expands Phase II Trial of ICT-107. |
|
|
Jun 9, 2011 |
754 |
| ImmunoCellular Therapeutics' ICT-107 Drug Candidate Featured in CBS Television News Story. |
|
|
Jun 8, 2011 |
498 |
| BioSante Pharmaceuticals Announces Lifting of Clinical Hold on GVAX Prostate Cancer Vaccine. |
|
|
Jun 6, 2011 |
1184 |
| Biovest Announces that BiovaxID[R] Personalized Cancer Vaccine is Featured in Journal of Clinical Oncology. |
|
|
Jun 1, 2011 |
1880 |
| PharmaNet Collaborates With the Cancer Immunotherapy Trials Network. |
|
|
Jun 1, 2011 |
638 |
| HPV vaccine for boys: stigmas fuel parents' reluctance: from the annual meeting of the society for adolescent health and medicine. |
London, Susan |
|
Jun 1, 2011 |
633 |
| The ACTG Immunizes First Subject in Clinical Trial of Profectus BioSciences' Therapeutic HIV DNA Vaccine. |
|
|
May 25, 2011 |
996 |
| ImmunoCellular Therapeutics to Present New Data from Phase I Study of ICT-107 in Glioblastoma Multiforme at ASCO 2011. |
|
|
May 24, 2011 |
828 |
| Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy. |
|
|
May 20, 2011 |
689 |
| Inovio Pharmaceuticals' Market-Leading Intellectual Property Recognized by MDB Capital Award. |
|
|
May 12, 2011 |
1071 |
| Biovest Reports New BiovaxID[R] Cancer Vaccine Manufacturing Site Has Been Completed at its Minnesota Cell Culture Center. |
|
|
May 11, 2011 |
899 |
| Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine. |
|
|
May 9, 2011 |
1928 |
| Research and Markets: Cancer Vaccines: From Research to Clinical Practice. |
|
|
May 9, 2011 |
404 |
| Geron Statement Regarding European Cancer Vaccine Patents. |
|
|
May 9, 2011 |
777 |
| Crushing cancer's defenses: vaccine approval offers hope while other armies muster. |
Strain, Daniel |
Cover story |
May 7, 2011 |
2692 |
| ImmunoCellular Therapeutics Announces Updated Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma. |
|
|
May 5, 2011 |
705 |
| Inovio Pharmaceuticals to Present at Scientific Conferences. |
|
Conference news |
May 4, 2011 |
910 |
| Some older adults not receiving potentially lifesaving services: report finds gaps in preventive care. |
Currie, Donya |
Clinical report |
May 1, 2011 |
333 |
| British doctors recommend bypassing free National Health Service vaccinations for prevention of HPV infection. |
|
Report |
May 1, 2011 |
355 |
| Cervical cancer screening - a new viral paradigm: cervical cancer is the second most frequent cancer among women in South Africa and worldwide. |
Richter, Karin Louise |
|
May 1, 2011 |
2702 |
| Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing. |
|
|
Apr 25, 2011 |
46746 |
| RWANDA,UNITED STATES : Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing. |
|
|
Apr 25, 2011 |
428 |
| Aduro BioTech Completes $19.25 Million Series B Financing. |
|
|
Apr 20, 2011 |
517 |
| Cancer Vaccines Poised to Reach $3 Billion in Sales by 2015. |
|
|
Apr 19, 2011 |
686 |
| Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C. |
|
Clinical report |
Apr 18, 2011 |
1807 |
| BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License. |
|
|
Apr 18, 2011 |
1224 |
| Aduro BioTech Licenses GVAX Pancreas from BioSante Pharmaceuticals to Develop a Therapeutic Vaccine in Conjunction with CRS-207 for Pancreatic Cancer. |
|
|
Apr 18, 2011 |
853 |
| Cross-town rivalry; Two companies vie to create cancer vaccine. |
|
|
Apr 17, 2011 |
1135 |
| New drug to fight cancer is trialled in the North. |
|
|
Apr 16, 2011 |
731 |
| Susan G. Komen for the Cure[R] Commits Nearly $58 Million in 2011 to Tackle Toughest Issues with New, Innovative Approaches to Breast Cancer Research. |
|
|
Apr 14, 2011 |
913 |
| CEL-SCI Corporation's Chief Scientific Officer to Present Data Supporting Innovative Treatments for Cancer at World Vaccine Congress on April 14th. |
|
|
Apr 13, 2011 |
666 |
| immatics to Receive Support From Pfizer for its Pivotal Phase III Study (IMPRINT) With IMA901, a Therapeutic Vaccine for Advanced Renal Cell Cancer Patients. |
|
Clinical report |
Apr 11, 2011 |
1087 |
| MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute. |
|
|
Apr 11, 2011 |
667 |
| Outsmarting Cancer Cells: Researchers Learn How They Spread. |
|
|
Apr 8, 2011 |
636 |
| Advaxis Receives FINRA Approval to Relist on OTC Bulletin Board. |
|
|
Apr 5, 2011 |
424 |
| Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research. |
|
|
Apr 4, 2011 |
1072 |
| RXi to buy Ariz. firm; Biotech company working on breast cancer vaccine. |
|
|
Apr 1, 2011 |
306 |
| Research and Markets: Breast Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011. |
|
|
Mar 30, 2011 |
571 |
| Research and Markets: Prostate Cancer Vaccines and Therapeutic Antibodies: Pipeline - 2011. |
|
|
Mar 30, 2011 |
489 |
| Inovio Pharmaceuticals to Present at Scientific Conferences. |
|
Conference news |
Mar 29, 2011 |
1363 |
| NIH study identifies gene that suppresses cell's immune activation. |
|
|
Mar 23, 2011 |
194 |
| ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis' Zometa; Physicians Still on the Fence About Dendreon's Provenge. |
|
|
Mar 22, 2011 |
1109 |
| Despite setbacks, Ca vaccine trials continue: a search on clinicaltrials.gov shows more than 100 studies that are recruiting or in active planning. |
Osterweil, Neil |
|
Mar 15, 2011 |
1570 |
| Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology. |
|
|
Mar 14, 2011 |
1417 |
| Biovest to Present at ROTH Capital OC Growth Stock Conference. |
|
Conference news |
Mar 9, 2011 |
659 |
| Reportlinker Adds Drug Delivery in Cancer - Technologies, Markets and Companies. |
|
|
Mar 7, 2011 |
765 |
| FDA approves Gardasil to prevent anal cancer. |
|
Brief article |
Mar 1, 2011 |
150 |
| Tap: novel targets for cancer vaccine development. |
Wilson, Glynn |
|
Mar 1, 2011 |
2089 |
| Vaccine-delivering nanoparticles may help fight HIV, malaria. |
|
|
Feb 24, 2011 |
455 |
| Biovest Secures Financing from State of Minnesota and City of Coon Rapids to Establish Manufacturing Site for Lymphoma Cancer Vaccine. |
|
|
Feb 24, 2011 |
1433 |
| Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences. |
|
Conference news |
Feb 22, 2011 |
1052 |
| Australian Market Report of February 21, 2011: Prima BioMed (ASX:PRR) To Commence Clinical Trial For Ovarian Cancer Immunotherapy Vaccine. |
|
|
Feb 21, 2011 |
333 |
| Govt cover- up job on cervical cancer vaccine. |
|
|
Feb 19, 2011 |
371 |
| Biovest, State of Minnesota and City of Coon Rapids to Host Press Conference to Introduce New Manufacturing Facility Partnership for Cancer Vaccine. |
|
|
Feb 17, 2011 |
1040 |
| Research and Markets: Triple Analysis: A Focus on Cancer Drug Development Strategies for Breast & Pancreatic Cancer. |
|
|
Feb 15, 2011 |
581 |
| Mentor Capital Adds Advaxis with Trojan Horse Cancer Vaccine to Cancer Immunotherapy Index. |
|
|
Feb 15, 2011 |
435 |
| Advaxis Included in the Mentor Capital Cancer Immunotherapy Index. |
|
|
Feb 15, 2011 |
759 |
| Quadrivalent HPV vaccine found to be effective in males. |
Moon, Mary Ann |
|
Feb 15, 2011 |
894 |
| Jab that prevents cervical cancer. |
|
|
Feb 7, 2011 |
331 |
| Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery. |
|
|
Feb 7, 2011 |
1286 |
| Inovio Pharmaceuticals' Dual-Antigen SynCon(TM) DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial. |
|
|
Feb 2, 2011 |
1389 |
| ImmunoCellular Therapeutics Announces First Patient Enrolled In Its Phase II Trial of ICT-107. |
|
|
Feb 2, 2011 |
777 |
| Leukaemia vaccine goes on clinical trial. |
|
|
Feb 1, 2011 |
106 |
| SCANCELL HOLDINGS PLC - SCIB1: Safety Review and Dose Escalation. |
|
|
Jan 31, 2011 |
635 |
| SCIB1: Safety Review and Dose Escalation. |
|
|
Jan 31, 2011 |
559 |
| University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology. |
|
|
Jan 31, 2011 |
3086 |
| Advaxis Science & Operations Officer Moderates Live Vaccine Panel at Cancer Drug Research Conference. |
|
Conference news |
Jan 28, 2011 |
714 |
| SCANCELL HOLDINGS PLC - Re: SCIB1 Clinical Trial Patient Recruitment. |
|
|
Jan 28, 2011 |
672 |
| Reportlinker Adds The Global Cancer Vaccine Market, 2nd Edition: Pipeline Analysis and Future Market Impact. |
|
|
Jan 27, 2011 |
705 |
| Inovio Pharmaceuticals Closes $24.3 Million Registered Offering. |
|
|
Jan 27, 2011 |
1085 |
| BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine. |
|
|
Jan 25, 2011 |
812 |
| Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study. |
|
|
Jan 25, 2011 |
1345 |
| Inovio Pharmaceuticals Announces $24.3 Million Registered Offering. |
|
|
Jan 24, 2011 |
1100 |
| Inovio Pharmaceuticals to Present at Phacilitate Vaccine Forum Washington 2011. |
|
|
Jan 20, 2011 |
1097 |
| SCANCELL HOLDINGS PLC - Issue of Equity. |
|
|
Jan 13, 2011 |
525 |
| Research and Markets: Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report. |
|
Report |
Jan 12, 2011 |
559 |
| Ladies: Take The Pearl Pledge to Protect Yourselves Against Cervical Cancer. |
|
|
Jan 6, 2011 |
1035 |
| Biovest to Present at OneMedForum Conference. |
|
|
Jan 6, 2011 |
800 |
| Profectus BioSciences Announces Initiation of Clinical Trial of IL-12 Enhanced Therapeutic HIV DNA Vaccine Delivered Using Electroporation. |
|
|
Jan 5, 2011 |
965 |
| Research and Markets: An Essential Triple Analysis on Cancer Vaccines, Protein Kinase Inhibitors and Antibodies. |
|
|
Jan 4, 2011 |
615 |
| Inovio Pharmaceuticals to Present at Biotech Showcase 2011. |
|
|
Jan 4, 2011 |
821 |
| ImmunoCellular Therapeutics Receives FDA Approval to Commence Phase II Trial of ICT-107. |
|
|
Jan 4, 2011 |
792 |
| Dear Dr Miriam. |
|
|
Jan 3, 2011 |
195 |
| Dear Dr Miriam. |
|
|
Jan 3, 2011 |
197 |
| Building better cancer vaccines: researchers on the Baylor Dallas campus are using diverse approaches to optimize immune response. |
Cherry, Lorraine |
Report |
Jan 1, 2011 |
3639 |
| SRI INTERNATIONAL/PHENOMATRIX TO DEVELOP CHEMOTHERAPIES. |
|
|
Dec 30, 2010 |
773 |
| FDA: Gardasil Approved to Prevent Anal Cancer. |
|
|
Dec 22, 2010 |
755 |
| US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL[R]. |
|
|
Dec 22, 2010 |
46028 |
| Biovest Issues Post-ASH Update for BiovaxID[R] Personalized Cancer Vaccine including Significance of Isotype Phase III Data. |
|
|
Dec 20, 2010 |
4239 |
| Research and Markets: Triple Analysis: Breast Cancer, Angiogenesis and Cancer Vaccines 2010. |
|
|
Dec 16, 2010 |
613 |
| Profectus Biosciences' GENEVAX IL-12 Adjuvant Significantly Improves pDNA Vaccine Performance in Phase I Human Trial. |
|
|
Dec 14, 2010 |
1164 |
| SCANCELL HOLDINGS PLC - Result of AGM. |
|
|
Dec 14, 2010 |
428 |
| Research and Markets: a Triple Analysis Focusing on Cancer Drug Development Strategies in Colorectal Cancer, Cancer Vaccines & Protein Kinase Inhibitors. |
|
|
Dec 10, 2010 |
623 |
| Preclinical Efficacy of Inovio Pharmaceuticals' Smallpox DNA Vaccine Featured in The Journal of Infectious Diseases. |
|
|
Dec 7, 2010 |
1646 |
| Geron Presents Clinical Data on Its Telomerase Vaccine at the 2010 American Society of Hematology Meeting. |
|
|
Dec 6, 2010 |
1409 |
| Research and Markets: Triple Analysis: Cancer Vaccines, Antibodies and Peptides. |
|
|
Dec 6, 2010 |
610 |
| Biovest Reports a Significant Discovery in Cancer Vaccines for Lymphoma: Vaccine Isotype Determines Improvement in Disease-Free Survival Following Vaccine Therapy. |
|
|
Dec 6, 2010 |
1542 |
| Lytix Biopharma and KAEL-GemVax Announce First Patient Treated in Clinical Trial to Combine LTX-315 and GV1001 Cancer Vaccine Immunotherapy. |
|
|
Dec 6, 2010 |
302 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Melanoma and Cancer Vaccines 2010. |
|
|
Dec 2, 2010 |
586 |
| SRI International and PhenoMatriX Collaborate to Develop Platin-Based Chemotherapies. |
|
|
Dec 2, 2010 |
1116 |
| Tolerx and the Cancer Research Institute Enter Collaboration to Accelerate Development of TRX518, a First-in-Class Anti-GITR Antibody for Cancer Treatment. |
|
|
Dec 1, 2010 |
1134 |
| New hopes for Newcastle. |
Moss, Ralph |
Report |
Dec 1, 2010 |
2316 |
| FDA committee considers Gardasil for anal cancer. |
Splete, Heidi |
|
Dec 1, 2010 |
375 |
| Research and Markets: a Triple Analysis Focusing on Cancer Drug Development Strategies in Leukemia, Cancer Vaccines & Protein Kinase Inhibitors. |
|
|
Nov 29, 2010 |
470 |
| Research and Markets: Triple Analysis on Colorectal Cancer, Prostate Cancer and Cancer Vaccines 2010. |
|
|
Nov 29, 2010 |
472 |
| Research and Markets: Triple Analysis on Colorectal Cancer, Pancreatic Cancer and Cancer Vaccines 2010. |
|
|
Nov 29, 2010 |
474 |
| Medicare Advisory Panel Endorses Prostate Cancer Vaccine. |
|
|
Nov 18, 2010 |
640 |
| FDA Advisory Committee Supports Approval of GARDASIL[R] for Prevention of Anal Cancer and AIN in both Men and Women. |
|
|
Nov 17, 2010 |
34200 |
| Research and Markets: Cancer Drug Blockbusters to 2016 - The Prospects & Challenges for 21 US$1 Billion Oncology Products. |
|
|
Nov 16, 2010 |
561 |
| Research and Markets: Triple Analysis: Lung Cancer, Apoptosis and Cancer Vaccines. |
|
|
Nov 15, 2010 |
606 |
| CERVICAL cancer should become a [...]. |
|
|
Nov 15, 2010 |
191 |
| New Phase III Data Analysis for BiovaxID[R], Personalized Lymphoma Vaccine, to Be Presented at ASH Annual Meeting. |
|
|
Nov 15, 2010 |
737 |
| CANCER VACCINE FOR GIRLS STILL SAFE; Teens suffer side-effects but docs tell parents: Don't worry. |
|
|
Nov 14, 2010 |
444 |
| ALERT ON CANCER VACCINE FOR GIRLS; Fears over side-effects. |
|
|
Nov 14, 2010 |
434 |
| CANCER VACCINE FORGIRLS STILLSAFE; Teens suffer side-effects but docs tell parents: Don't worry. |
|
|
Nov 14, 2010 |
437 |
| Cervical cancer jab 'means fewer tests'. |
|
|
Nov 12, 2010 |
237 |
| London Genetics and Astrimmune to Collaborate on Cancer Vaccine. |
|
|
Nov 12, 2010 |
783 |
| Vaccine 'should make cervical cancer rare'. |
|
|
Nov 10, 2010 |
227 |
| Cervical cancer jab 'means fewer tests'. |
|
|
Nov 10, 2010 |
237 |
| Dutch Ministry of Health Grants Vaccinogen's OncoVAX Cancer Vaccine Hospital Exemption Status. |
|
|
Nov 9, 2010 |
473 |
| Advaxis Enters into Collaboration with the University of British Columbia. |
|
|
Nov 8, 2010 |
704 |
| Accentia Announces Federal Grant Awarded to Support Advancement of Revimmune[TM] to Treat Autoimmune Diseases; Biovest Subsidiary Also Receives Award for Cancer Vaccine. |
|
|
Nov 4, 2010 |
872 |
| Biovest Announces Federal Grant Awarded to Support Advancement of BiovaxID Lymphoma Cancer Vaccine. |
|
|
Nov 4, 2010 |
743 |
| Inovio Pharmaceuticals Receives $733,438 Grant Under the Patient Protection and Affordable Care Program. |
|
|
Nov 1, 2010 |
850 |
| Advaxis Signs CRADA with Vaccine Branch of NCI. |
|
|
Oct 29, 2010 |
546 |
| Inovio Pharmaceuticals to Present at Investor Conferences In New York and Miami. |
|
Conference news |
Oct 28, 2010 |
959 |
| Research and Markets: Triple Analysis: Colorectal Cancer, Angiogenesis and Cancer Vaccines 2010 Provides Systems, Analytical and Strategic Support. |
|
|
Oct 27, 2010 |
676 |
| Inovio Pharmaceuticals Minimally-Invasive DNA Vaccine Delivery Device Featured in the Journal Gene Therapy. |
|
|
Oct 25, 2010 |
1252 |
